Highlighted News
2024/06
illumiSonics Selected for INOVAIT Focus Fund Investment to Revolutionize Intraoperative Cancer Diagnosis illumiSonics selected as one of the seven recipients of the INOVAIT Focus Fund. This funding will support a groundbreaking development effort titled "First Accurate Fresh Bulk Tissue Imaging with Multiplex Smart Staining and AI-Assisted Diagnosis for Rapid Intraoperative Cancer Assessment." read more. |
2024/04
How lasers and AI could help detect cancerous tissue in minutes Featured on CTV News Kitchener. A cancer detecting system built from scratch at the University of Waterloo (UW) is nearing completion and could be on the market within two years. read more. |
2023/11
IllumiSonics Inc., Announces Publication of Landmark Clinical Validation Study in Breast Cancer PARS® H&E images equivalent to traditional gold-standard H&E images with 98% diagnostic concordance for cancer versus benign. read more. |
News & Press Releases
2024
|
2024/06
illumiSonics Selected for INOVAIT Focus Fund Investment to Revolutionize Intraoperative Cancer Diagnosis |
illumiSonics selected as one of the seven recipients of the INOVAIT Focus Fund. This funding will support a groundbreaking development effort titled "First Accurate Fresh Bulk Tissue Imaging with Multiplex Smart Staining and AI-Assisted Diagnosis for Rapid Intraoperative Cancer Assessment" - read more. |
|
2024/04
How lasers and AI could help detect cancerous tissue in minutes |
Featured on CTV News Kitchener. A cancer detecting system built from scratch at the University of Waterloo (UW) is nearing completion and could be on the market within two years - read more. |
|
2024/03
illumiSonics’ technology a revolutionary step in cancer diagnosis |
When it comes to treating cancer, the time it takes to complete a diagnosis can have a significant impact on patient outcomes. In the U.S., the average time to complete a diagnosis is over five months, which can delay lifesaving treatments like chemotherapy and radiation therapy - read more. |
2023
|
2023/11
IllumiSonics Inc., Announces Publication of Landmark Clinical Validation Study in Breast Cancer |
PARS® H&E images equivalent to traditional gold-standard H&E images with 98% diagnostic concordance for cancer versus benign - read more. |
|
2023/07
IllumiSonics label-free fresh tissue histology imaging to be presented at the 25th World Congress of Dermatology |
illumiSonics, a leader in label-free imaging, is pleased to announce that Dr. Ally-Khan Somani will be presenting on PARS fresh skin tissue imaging at the 25th World Congress of Dermatology in Singapore, July 3rd-8th, 2023 - read more. |
|
2023/04
Dr. Jill Stefanelli Joins illumiSonics Inc., as an Advisory Board Member and Consultant in Digital and Molecular Pathology |
illumiSonics Inc., is proud to announce that Jill Stefanelli, PhD has joined the company as an Advisory Board Member and Consultant in Digital and Molecular Pathology -read more. |
2022
|
2022/ 12
Glen Mackey Joins illumiSonics Inc. as a Member of the Board of Directors |
illumiSonics Inc. is pleased to announce that Glen E. Mackey has joined the company as a member of the Board of Directors - read more. |
|
2022 / 03
Top 100 in Physics |
Our paper published in Scientific Reports, "Functional and structural ophthalmic imaging using noncontact multimodal photoacoustic remote sensing microscopy and optical coherence tomography," is one of the top 100 most downloaded physics papers that were published in 2021 - read more. |
|
2022 / 03
PARS® featured in BioPhotonics Magazine |
Photoacoustic Remote Sensing Reveals Clues About Cancer, Blindness. By leveraging the imaging contrast created in the light-matter interactions caused by laser excitation, photoacoustic remote sensing provides detailed information in real time - read more. |
|
2022 / 01
«Looking Disease in the Eye» PARS® featured in IEEE Pulse magazine |
IEEE Pulse magazine of the Engineering in Medicine and Biology Society has highlighted PARS and PhotoMedicine Labs research in the field of ophthalmology - read more. |
2021 and Earlier
|
2021 / 08
illumiSonics featured on Microsoft Customer Stories |
illumiSonics is working to accelerate real-time, touchless laser research geared to revolutionizing medical imaging with Azure - read more. |
|
2021/08
illumiSonics featured on Microsoft News Centre Canada |
HIMSS21: Empowering a patient-centered healthcare model - read more. |
|
2020 / 09
First time reported label-free, non-contact, in-vivo ophthalmic Imaging using PARS® |
Professor Parsin Haji Reza and his team at the PhotoMedicine Labs for the first time reported label-free, non-contact, in-vivo ophthalmic imaging using photoacoustic remote sensing (PARS®) microscopy. This work is the first non-contact photoacoustic imaging of ocular structures - read more. |
|
2019 / 11
UW researchers develop imaging tech that could ‘revolutionize’ cancer surgery |
There is no cure for cancer, but treatment could be dramatically improved thanks to an invention out of the University of Waterloo. Parsin Haji Reza and his team at the university are working to revolutionize cancer detection - read more. |